Narrow search
Showing 1 - 10 of 99
Cover Image
EPIC SYSTEMS: MARKETING SUCKS - Neal Patterson isn't the only health care IT billionaire in America.
Moukheiber, Zina - In: Forbes : business and finance (2012), pp. 92-99
Persistent link: https://www.econbiz.de/10009966232
Cover Image
Fixing the Flu - Mess Can Chiron do it?
Moukheiber, Zina - In: Forbes : business and finance (2004), pp. 93-95
Persistent link: https://www.econbiz.de/10006241237
Cover Image
Entrepreneurs - Slim Pickings - A low-carb retailing disaster.
Moukheiber, Zina - In: Forbes : business and finance (2004), pp. 134-135
Persistent link: https://www.econbiz.de/10006243157
Cover Image
Health - Puff Daddy - Alejandro Zaffaroni's new take on an old drug-delivery method gets its inspiration from cigarettes.
Moukheiber, Zina - In: Forbes : business and finance (2004), pp. 195-197
Persistent link: https://www.econbiz.de/10006247079
Cover Image
Health - Mind Over Matter - Neural prosthetics are slowly becoming reality.
Moukheiber, Zina - In: Forbes : business and finance (2004), pp. 186-189
Persistent link: https://www.econbiz.de/10006248345
Cover Image
Companies, People, Ideas - The Future Is in Antivirals - Little-known Gilead stakes a claim in a fast-growing drug market.
Dolan, Kerry A.; Moukheiber, Zina - In: Forbes : business and finance (2003), pp. 98-107
Persistent link: https://www.econbiz.de/10006252168
Cover Image
OutFront - Junk DNA? A tiny Aussie firm has claimed rights to vast tracts of the human genome.
Moukheiber, Zina - In: Forbes : business and finance (2003), pp. 52-53
Persistent link: https://www.econbiz.de/10006253059
Cover Image
Health - Double Agent - Does AstraZeneca have a better blood thinner?
Moukheiber, Zina - In: Forbes : business and finance (2003), pp. 132-136
Persistent link: https://www.econbiz.de/10006253602
Cover Image
Medical Merlins - Behind every breaktrough drug is a handful of unknown geniuses who conjured up what no one had dreamed of before
Lnagreth, Robert; Moukheiber, Zina - In: Forbes : business and finance (2003), pp. 113-127
Persistent link: https://www.econbiz.de/10006255422
Cover Image
Health - Hunger Pangs - Breakthrough obesity drugs often leave dashed hopes and lawsuits in their wake. Regeneron's Axokine aims to break that losing streak.
Moukheiber, Zina - In: Forbes : business and finance (2002), pp. 273-277
Persistent link: https://www.econbiz.de/10006260338